Literature DB >> 25990344

Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Felix Mahfoud1, Michael Böhm2, Michel Azizi3, Atul Pathak4, Isabelle Durand Zaleski5, Sebastian Ewen2, Kostantinos Tsioufis6, Bert Andersson7, Peter J Blankestijn8, Michel Burnier9, Gilles Chatellier10, Sameer Gafoor11, Guido Grassi12, Michael Joner13, Sverre E Kjeldsen14, Thomas Felix Lüscher15, Melvin D Lobo16, Chaim Lotan17, Gianfranco Parati18, Josep Redon19, Luis Ruilope20, Isabella Sudano15, Christian Ukena2, Evert van Leeuwen21, Massimo Volpe22, Stephan Windecker23, Adam Witkowski24, William Wijns25, Thomas Zeller26, Roland E Schmieder27.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25990344     DOI: 10.1093/eurheartj/ehv192

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  64 in total

1.  What is the benefit of renal denervation?

Authors:  Takuya Kishi
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

Review 2.  The rise, fall, and possible resurrection of renal denervation.

Authors:  Rajiv Gulati; Claire E Raphael; Manuela Negoita; Stuart J Pocock; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

Review 3.  Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis.

Authors:  Dasheng Lu; Kai Wang; Qian Liu; Shengchan Wang; Qi Zhang; Qijun Shan
Journal:  Clin Res Cardiol       Date:  2016-02-02       Impact factor: 5.460

Review 4.  Hypertension: history and development of established and novel treatments.

Authors:  Milan Wolf; Sebastian Ewen; Felix Mahfoud; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

5.  Stereotactic Radiotherapy for Renal Denervation: To Beam, or Not to Beam?

Authors:  Felix Mahfoud; Elazer Edelman; Nikhilesh Bhatt
Journal:  J Am Coll Cardiol       Date:  2019-10-01       Impact factor: 24.094

6.  Heart failure: Macrophages take centre stage in the heart-brain-kidney axis.

Authors:  Herman H W Silljé; Rudolf A de Boer
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

Review 7.  Global cardiovascular protection in chronic kidney disease.

Authors:  Gema Ruiz-Hurtado; Pantelis Sarafidis; María S Fernández-Alfonso; Bernard Waeber; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

8.  Catheter-based renal denervation in hypertension: heading for new shores.

Authors:  Felix Mahfoud; Michael Böhm; Elazer R Edelman
Journal:  J Hypertens       Date:  2018-01       Impact factor: 4.844

Review 9.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

10.  Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies.

Authors:  Marco Pappaccogli; Michele Covella; Elena Berra; Chiara Fulcheri; Silvia Di Monaco; Elisa Perlo; Jacopo Burrello; Silvia Monticone; Denis Rossato; Franco Rabbia; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.